Model-informed drug development to support nemolizumab clinical development in adults and adolescents with moderate to severe atopic dermatitis.

Br J Clin Pharmacol · 2026 · PMC13206448 · PMID 41539329

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

GOF plots were acceptable (Figures S9 and S10 ), although PP NRS showed a trend of under‐predicting lower scores.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.